CLDWW Calidi Biotherapeutics, Inc.
Price Chart
Executive Summary
Calidi Biotherapeutics issued an amended and restated warrant to purchase up to 17,391,304 shares of common stock at $0.23 per share to an accredited investor. The amendment raises the minimum vesting acquisition amount from $500,000 to $1,000,000, extends the vesting termination date to September 30, 2026, and conditions exercise on stockholder approval. This is a routine restructuring of existing warrant terms with no new capital raised.
Actionable Insight
Monitor for stockholder approval vote and any subsequent share acquisitions by the holder that would trigger warrant vesting. The $0.23 exercise price and 17.4M share overhang represent potential future dilution if the holder meets the $1M minimum purchase condition.
Key Facts
- Amended and restated warrant issued May 28, 2026, replacing the May 6, 2026 warrant
- Warrant covers up to 17,391,304 unvested shares at $0.23 exercise price
- Minimum Vesting Acquisition Amount increased from $500,000 to $1,000,000
- Vesting Termination Date extended from July 8, 2026 to September 30, 2026
- Exercise conditioned on stockholder approval per NYSE American rules
- Issued in private placement under Section 4(a)(2) and Rule 506(b)
Financial Impact
No new capital raised; warrant terms restructured with higher vesting threshold ($1M vs $500K) and extended deadline
Risk Factors
- Potential dilution of up to 17.4M shares if warrant vests and is exercised
- Stockholder approval required before any exercise — failure to obtain could void the warrant
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-026415 |
| Document: form8-k.htm | 0001493152-26-026415 |
| Document: 0001493152-26-026415-index-headers.html | 0001493152-26-026415 |
| Document: 0001493152-26-026415-index.html | 0001493152-26-026415 |
| Document: 0001493152-26-026415.txt | 0001493152-26-026415 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 29, 2026
14d ago
|
8-K
| — | awaiting T+20 | — | — |
|
May 8, 2026
5w ago
|
8-K
| — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access